We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
-7.25%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
AUM
$171M
AUM Growth
+$4.01M
Cap. Flow
+$16.8M
Cap. Flow %
9.85%
Top 10 Hldgs %
55.16%
Holding
228
New
107
Increased
39
Reduced
38
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 4.05%
2 Communication Services 3.01%
3 Financials 1.84%
4 Healthcare 1.26%
5 Consumer Staples 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICLN icon
201
iShares Global Clean Energy ETF
ICLN
$2.36B
$9K 0.01%
425
-45
-10% -$881
ORTX
202
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$8K ﹤0.01%
+1,070
New +$10.5K
ATNX
203
DELISTED
Athenex, Inc. Common Stock
ATNX
$8K ﹤0.01%
+500
New +$9.78K
CEMI
204
DELISTED
Chembio diagnostics, Inc.
CEMI
$8K ﹤0.01%
+10,000
New +$9.33K
AKBA icon
205
Akebia Therapeutics
AKBA
$354M
$7K ﹤0.01%
+10,000
New +$21.4K
SPLV icon
206
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
$7K ﹤0.01%
109
IWS icon
207
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$6K ﹤0.01%
49
VFH icon
208
Vanguard Financials ETF
VFH
$13.6B
$5K ﹤0.01%
+51
New +$4.88K
IEFA icon
209
iShares Core MSCI EAFE ETF
IEFA
$191B
$4K ﹤0.01%
55
SPYV icon
210
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.4B
$4K ﹤0.01%
92
VBR icon
211
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
$4K ﹤0.01%
22
POTX
212
DELISTED
Global X Cannabis ETF
POTX
$4K ﹤0.01%
110
NBRV
213
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$4K ﹤0.01%
+400
New +$4.86K
VTWO icon
214
Vanguard Russell 2000 ETF
VTWO
$17.6B
$2K ﹤0.01%
24
PBW icon
215
Invesco WilderHill Clean Energy ETF
PBW
$406M
$1K ﹤0.01%
10
-110
-92% -$6.59K
EWS icon
216
iShares MSCI Singapore ETF
EWS
$1.05B
$0 ﹤0.01%
1
IEI icon
217
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
-257
Closed -$33K
IVV icon
218
iShares Core S&P 500 ETF
IVV
$881B
-441
Closed -$210K
NFLX icon
219
Netflix
NFLX
$302B
-4,210
Closed -$254K
PCY icon
220
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
-2,935
Closed -$77K
PEP icon
221
PepsiCo
PEP
$190B
-1,175
Closed -$204K
RSP icon
222
Invesco S&P 500 Equal Weight ETF
RSP
$98B
$0 ﹤0.01%
1
SBUX icon
223
Starbucks
SBUX
$120B
-2,381
Closed -$279K
SPHQ icon
224
Invesco S&P 500 Quality ETF
SPHQ
$19.5B
-1,741
Closed -$93K
SPYM
225
State Street SPDR Portfolio S&P 500 ETF
SPYM
$164B
-2,885
Closed -$161K

Similar funds

Running Point Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Running Point Capital Advisors held 228 positions worth $171M, up 2.4% from $167M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Running Point Capital Advisors deployed $16.8M of net new capital in Q1 2022, opening 107 new positions and adding to 39 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 11,412 shares worth $558K.

By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 5.6% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $2.01M trimmed.

  • Running Point Capital Advisors's largest Q1 2022 buy was JPMorgan International Bond Opportunities ETF: 11,412 shares worth $558K.
  • Running Point Capital Advisors added most to iShares Core MSCI Emerging Markets ETF in Q1 2022, an estimated $3.44M increase.
  • Running Point Capital Advisors's biggest Q1 2022 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $2.01M.
  • Running Point Capital Advisors fully exited Starbucks in Q1 2022, selling an estimated $279K.
  • Running Point Capital Advisors's ten largest holdings make up 55% of its $171M portfolio in Q1 2022.
  • Running Point Capital Advisors opened 107 new positions and closed 10 in Q1 2022.
  • Running Point Capital Advisors's portfolio value rose 2.4% quarter-over-quarter to $171M.

Based on Running Point Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.